Moretto R, Giordano M, Poma AM, Passardi A, et al. Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study. Eur J Cancer 2021;153:16-26.
PMID: 34126333